摘要
组蛋白脱乙酰酶(HDACs)在调控肿瘤发生和发展过程中多种蛋白的表达和活性中起着至关重要的作用。HDAC活性导致不允许的CHROO通过抹去组蛋白底物中乙酰基的构象,最终形成转录抑制在肿瘤发生中具有重要作用的基因。除组蛋白外,HDACS Deacetylate含有多种非组蛋白,包括参与调控细胞生长、分化和凋亡的转录因子。组蛋白去乙酰化酶抑制剂(Hdaci)是小分子。抑制HDACs,从而调节其生物活性。新的证据表明,非组蛋白的乙酰化在包括mrna在内的各种细胞过程中起着至关重要的作用。稳定性,蛋白质定位和降解。非组蛋白如核因子kappab(nf-кb)、热休克蛋白90(Hsp 90)及相合蛋白(Frataxin)的异常转换或表达包括癌症在内的疾病。本文探讨了HDACi的治疗作用,特别强调对临床相关非组蛋白分子靶点的调控。广泛的细节还提供了非组蛋白蛋白质和它们在疾病状态中的放松管制。 此外,HDACI触发的基础分子机制通过调节来克服疾病状态预定义的目标也得到了启发。本文强烈建议在对因非组蛋白deregula并发症的治疗干预的HDACi希望使用支票电托收,象征式互动.
关键词: 乙酰化,去乙酰化,HATS,HDACS,HDACi,组蛋白,非组蛋白蛋白.
Current Drug Targets
Title:Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention
Volume: 19 Issue: 6
关键词: 乙酰化,去乙酰化,HATS,HDACS,HDACi,组蛋白,非组蛋白蛋白.
摘要: Histone deacetylases (HDACs) play a crucial role in regulating the expression and activity of myriad of proteins involved in tumour onset and progression. HDAC activity results in a nonpermissive chromatin conformation by erasing acetyl moiety from histone substrates culminating in transcriptional repression of those genes having significant role in tumourigenesis. Apart from histones, HDACs deacetylate a variety of non-histone proteins including transcription factors involved in controlling cell growth, differentiation and apoptosis. Histone deacetylase inhibitors (HDACi) are small-molecules restraining HDACs and hence modulating their biological activity. Emerging evidences suggest that acetylation of non-histone proteins plays a critical role in various cellular processes including mRNA stability, protein localization and degradation. Abnormal turnover or expression of non-histone proteins like nuclear factor- kappaB (NF-κB), heat shock protein 90 (HSP90) and frataxin fuels various diseases including cancer. The present article explores the therapeutic role of HDACi with special emphasis on modulation of clinically relevant non-histone molecular targets. Extensive details regarding the non-histone proteins and their deregulation in disease states have also been provided. Moreover, the underlying molecular mechanism triggered by HDACi to overcome disease states by modulating the predefined targets has also been illuminated. The article strongly suggests the promising use of HDACi in therapeutic intervention against complications arising due to non-histone protein deregulation.
Export Options
About this article
Cite this article as:
Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention, Current Drug Targets 2018; 19 (6) . https://dx.doi.org/10.2174/1389450117666160527143257
DOI https://dx.doi.org/10.2174/1389450117666160527143257 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Reactive Oxygen Species in Vascular Wall
Cardiovascular & Hematological Disorders-Drug Targets Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
Current Pharmaceutical Design Gender Related Issues in the Management of Heart Failure
Current Pharmaceutical Design Heart Failure in East Asia
Current Cardiology Reviews Calcium Ions in Inherited Cardiomyopathies
Medicinal Chemistry Endotherapia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nutrition, Nitrogen Requirements, Exercise and Chemotherapy-Induced Toxicity in Cancer Patients. A puzzle of Contrasting Truths?
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot topic: Innate Immunity Molecules S100A8/A9 Involved in Stress Response and Cancer Biology (Guest Editors: Claus Kerkhoff and Saeid Ghavami)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Modelling Human Disease with Pluripotent Stem Cells
Current Gene Therapy Chagas Heart Disease Pathogenesis: One Mechanism or Many?
Current Molecular Medicine Sepsis-induced Cardiomyopathy
Current Cardiology Reviews Fabry Disease Cardiomyopathy: from Genes to Clinical Manifestations
Current Pharmaceutical Biotechnology Clinical Features and Disease Damage Risk Factors in an Egyptian SLE Cohort: A Multicenter Study
Current Rheumatology Reviews Vascular Disease and Insulin-Like Growth Factor-1
Vascular Disease Prevention (Discontinued) MicroRNAs in Human Diseases
Recent Patents on DNA & Gene Sequences Therapeutic Potential of HDAC Inhibitors in the Treatment of Cardiac Diseases: A Short Review
Current Drug Targets Potential Roles of MyomiRs in Cardiac Development and Related Diseases
Current Cardiology Reviews Measurement of Nitric Oxide and Reactive Oxygen Species in the Vascular Wall
Current Analytical Chemistry The Association Between HIV/AIDS During Pregnancy and Fetal Growth Parameters in Florida: A Population Based Study
Current HIV Research Mitochondrially Targeted Antioxidants for the Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery